Abstract
ABSTRACT: Attempts at treatment of glycogenosis type II and other lysosomal storage disorders by enzyme replacement have been reported. Parenteral enzyme administration has been ineffectual. Treatment by bone marrow transplantation is currently under investigation. We have used cultured skeletal muscle cells from a patient with infantile glycogenosis type II to study fundamental aspects of enzyme replacement therapy. Efficient uptake of acid α-glucosidase was achieved by using the mannose-6-phosphate receptor on the cell surface as a target for an enzyme precursor with phosphorylated high-mannose types carbohydrate chains purified from human urine. We found that the enzyme was channeled to the lysosomes and converted to mature acid α-glucosidase. Glycogen storage was reversed. The results are discussed in relation to treatment of glycogenosis type II.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Der Ploeg, A., B. Loonen, M., Bolhuis, P. et al. Receptor-Mediated Uptake of Acid α-Glucosidase Corrects Lysosomal Glycogen Storage in Cultured Skeletal Muscle. Pediatr Res 24, 90–94 (1988). https://doi.org/10.1203/00006450-198807000-00021
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-198807000-00021
This article is cited by
-
Effects of a higher dose of alglucosidase alfa on ventilator‐free survival and motor outcome in classic infantile Pompe disease: an open‐label single‐center study
Journal of Inherited Metabolic Disease (2016)
-
Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model
Gene Therapy (2004)
-
Enzyme therapy for Pompe disease: from science to industrial enterprise
European Journal of Pediatrics (2002)
-
Hereditary human myopathies in muscle culture
The Italian Journal of Neurological Sciences (1991)
-
Muscle glycogenosis
Journal of Inherited Metabolic Disease (1990)